Consistent with our observations are recent findings by Bianco et al. [35] that overexpression of Claspin and Timeless, themselves E2F transcription factor targets, play a key role in ATR-CHK1 signaling pathway-mediated protection against RS in cancer cells. The gene discussed is CHEK1; the disease is cancer.